drugset / Trial / NCT00861497
Bifeprunox Extension to Extension Study in Patients With Schizophrenia
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to provide access to bifeprunox for patients, who have completed previous studies with bifeprunox, and require continued treatment with bifeprunox, other treatment not being adequate. A further purpose is to investigate the safety and side-effects of bifeprunox during long-term treatment.
Timeline
- Start
- 2006-01
- Primary completion
- 2008-01
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bifeprunox | Small molecule | 20 mg | — |
| Subject | Bifeprunox | Small molecule | 30 mg | — |
| Subject | Bifeprunox | Small molecule | 40 mg | — |